ArticleCureus2026
Cutaneous Angiomyolipoma of the Forearm.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiomyolipoma (AML) is defined as a benign tumour that is commonly identified in the kidneys, and most cases are associated with tuberous sclerosis. Although extrarenal AML cases have been reported, the association with the liver remains the most prevalent. We hereby report a rare case of cutaneous AML on the forearm of a 62-year-old gentleman, enduring for 10 years. Histopathology of AML revealed a combination of mature adipose tissue, thick-walled blood vessels, and smooth muscle cells, which distinguishes AML from other tissue tumours, such as lipoma, angiolipoma, hemangioma, and other mixed mesenchymal neoplasms. Immunochemistry was negative for human melanoma black-45 (HMB-45), emphasising the diagnosis of cutaneous AML and excluding it from renal and extrarenal AML. Cutaneous AML is a well-circumscribed, solitary, and non-invasive tumour that can be completely removed via surgery without recurrence. We want to highlight the importance of histopathology and immunohistochemistry evaluation in identifying cutaneous AML. We report a case of a 62-year-old gentleman who presented with a painless and gradually enlarging single subcutaneous swelling on his left forearm for a duration of 10 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.